Care Pathway for Lupus Nephritis
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 patients. Activities include answering surveys and participating in an interview.
Objectives include: 1) Assess feasibility and acceptability of the LN Care Pathway, 2) evaluate user experiences to identify opportunities for improvement, and 3) explore the preliminary effect of this pathway on medication adherence and clinical outcomes.
Who Is on the Research Team?
Kai Sun, MD, MS
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for adults (18+) who are patients at Duke clinics, have a current diagnosis of lupus with kidney involvement (lupus nephritis), can give consent, and are able to attend telemedicine visits. Both newly diagnosed and ongoing cases can join.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Lupus Nephritis (LN) Care Pathway
Trial Overview
The study is testing a new care pathway for managing lupus nephritis. Participants will follow this care plan, answer surveys, and take part in interviews to see if the approach helps with medication use and health outcomes.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participants receive the same LN Care Pathway intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Rheumatology Research Foundation
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.